Online first
Editorial
Published online: 2024-10-28
Late gadolinium enhancement cardiac magnetic resonance in aortic stenosis: Where do we stand today?
Pubmed: 39535958
Abstract
Not available
References
- Pibarot P, Clavel MA. Live longer and better without aortic valve stenosis. Lancet Healthy Longev. 2022; 3(9): e573–e574.
- Yarbrough WM, Mukherjee R, Ikonomidis JS, et al. Myocardial remodeling with aortic stenosis and after aortic valve replacement: Mechanisms and future prognostic implications. J Thorac Cardiovasc Surg. 2012; 143(3): 656–664.
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2021; 43(7): 561–632.
- Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: Structural deterioration and compensatory mechanisms. Circulation. 2003; 107(7): 984–991.
- Thornton GD, Vassiliou VS, Musa TA, et al. Myocardial scar and mortality in severe aortic stenosis. Circulation. 2018; 138(18): 1935–1947.
- Papanastasiou CA, Kokkinidis DG, Kampaktsis PN, et al. The prognostic role of late gadolinium enhancement in aortic stenosis: A systematic review and meta-analysis. JACC Cardiovasc Imaging. 2020; 13(2 Pt 1): 385–392.
- Thornton GD, Vassiliou VS, Musa TA, et al. Myocardial scar and remodelling predict long-term mortality in severe aortic stenosis beyond 10 years. Eur Heart J. 2024; 45(22): 2019–2022.
- Orłowska-Baranowska E, Nieznańska M, Marczak M, et al. Late gadolinium enhancement in aortic stenosis: Is it an indication to surgical treatment in asymptomatic patients? Pol Heart J. 2024 [Epub ahead of print].
